What is TB-500?
TB-500 is a synthetic analogue of Thymosin Beta-4, a naturally occurring peptide found in high concentrations in blood platelets, wound fluid, and various tissues throughout the body. It plays a central role in the body's natural healing and recovery processes, making it one of the most researched peptides for injury repair and performance recovery.
Mechanism of Action
TB-500 works primarily by upregulating actin — a protein essential for cell structure and movement. By promoting actin polymerisation, TB-500 facilitates cell migration to injury sites, accelerating tissue repair. It also promotes angiogenesis, reduces inflammation, and supports the differentiation of stem cells into specialised repair cells. Its low molecular weight and flexible structure allow it to travel systemically, making it effective even when administered away from the injury site.
Key Research Applications
- Skin Regeneration: In vitro and preclinical studies have reported increased dermal thickness and improvements in collagen density markers. Researchers have observed changes in fine line and wrinkle depth in some study models.
- Wound Healing: Animal model research has documented accelerated wound closure in burn and surgical incision models, with investigators attributing effects to fibroblast proliferation and collagen synthesis activity.
- Hair Growth: Preclinical research has investigated GHK-Cu's effects on hair follicle morphology and growth cycle activity, with some studies reporting increased follicle size. Research into androgenic alopecia applications remains at an early stage.
- Anti-Inflammatory: In vitro studies have reported reductions in pro-inflammatory cytokine expression and oxidative stress markers following GHK-Cu exposure.
-
Neuroprotection: Early-stage research has explored potential nerve regeneration and cognitive marker effects in preclinical models. These findings are preliminary.
Important Notes
GHK-Cu is supplied strictly for in vitro and laboratory research purposes. All information presented is based on preclinical animal studies and in vitro data. These findings have not been replicated in human clinical trials and should not be interpreted as evidence of efficacy in humans. This content does not constitute medical advice and is not intended to inform any therapeutic or clinical decision.